Mesenchymal stem cells are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, and adipocytes. They are used in research and therapies for various medical conditions such as graft-versus-host disease, Crohn’s disease, heart disease, diabetes, and neurological disorders.
Rising awareness about the therapeutic benefits of mesenchymal stem cells and increasing investment in stem cell research are expected to drive the growth of the mesenchymal stem cells market during the forecast period. Mesenchymal stem cells have shown promising results for treatment of various diseases in preclinical and clinical studies. They have immunomodulatory properties and differentiation abilities that allow their use in various regenerative medicine applications.
Furthermore, absence of ethical issues associated with the use of mesenchymal stem cells, as compared to other sources of stem cells, is further expected to support market growth over the forecast period.
Mesenchymal Stem Cells Market Drivers
The growing use of mesenchymal stem cells market in regenerative medicine provides a significant growth opportunity in the market
Mesenchymal stem cells have the potential to regenerate and repair damaged tissues. They are being increasingly used in regenerative medicine applications like treatment of osteoarthritis, cardiovascular diseases, neurological diseases, etc. The robust research activity and growing clinical trials focusing on therapeutic use of MSCs are major factors driving the growth of this market. According to researchers, MSCs have shown promising results for therapies for conditions like myocardial infarction, graft-versus-host disease, Crohn’s disease, etc. This is creating substantial demand for MSCs and contributing significantly to market growth.
Increasing investments in stem cell therapy and rising R&D activities
There has been a substantial rise in funding and investments for stem cell research from both public and private sources over the past decade. Government as well as private organizations are investing heavily in R&D activities focused on developing stem cell therapeutics. For instance, the National Institutes of Health (NIH) funding for stem cell research was around $1.45 billion in 2020. Similarly, private equity investments in companies focusing on stem cell therapies have risen considerably. Such increased funding and focus on R&D is supporting the ongoing clinical research as well as development of new applications of MSCs, thereby driving the growth of this market.
Mesenchymal Stem Cells Market Restrain
High costs associated with stem cell therapy and storage of cells
One of the major challenges in the widespread adoption of mesenchymal stem cells is their high treatment and storage costs. The procedure of isolating MSCs from donor tissues and culturing them on a large scale under cGMP conditions is an expensive process. Also, once harvested, MSCs must be cryopreserved for storage and future use. However, cryopreservation and long-term storage in stem cell banks is also costly. These costs often get passed on to patients in the form of high therapy charges making stem cell therapies unaffordable for many. This price sensitivity acts as a major restraint for the mesenchymal stem cells market.
Mesenchymal Stem Cells Market Opportunity
Untapped potential of mesenchymal stem cells in developing novel cell and gene therapies
While majority of current research is focused on using mesenchymal stem cells for regenerative therapies, there remains a huge untapped potential for developing novel cell-based and gene therapies. MSCs have many advantages like low immunogenicity, immunosuppressive properties and easy isolation that make them ideal candidates for applications beyond just regenerative medicine. For instance, MSCs are now being evaluated as potential drug delivery vehicles for targeted cancer therapies. Gene-modified MSCs are being studied for applications in diseases like cystic fibrosis. Overall, the ability of MSCs to serve as effective delivery vectors and assist in developing advanced cell and gene therapies presents a major market opportunity over the coming years.
Mesenchymal Stem Cells Market Trends
Rise in adoption of good manufacturing practices (GMP) for stem cell production and processing
With the growing clinical translation of stem cell therapies, quality standards for stem cell manufacturing are becoming increasingly important. Regulatory authorities worldwide are promoting the adoption of current Good Manufacturing Practices (cGMP) to ensure consistent high quality of cultured stem cell products. More players in the mesenchymal stem cells market are now following cGMP guidelines for isolation, expansion, cryopreservation and characterization of cells. This is helping improve the reproducibility and safety of stem cell products. The trend towards cGMP-compliant stem cell manufacturing using closed and automated processes is expected to continue in the future. This will enhance the therapeutic potential as well as commercial viability of various stem cell-based products.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it